THE PARAMETERS OF THE HEMOSTATIC SYSTEM, GENE POLYMORPHISMS IN CHILDREN WITH THROMBOTIC EVENTS IN THE PEDIATRIC CLINIC OF NOVOSIBIRSK STATE REGIONAL CLINICAL HOSPITAL
https://doi.org/10.15372/SSMJ20200118
Abstract
The aim of the research was to study the effect of genetic predictors of thrombotic/ischemic events in children with the developed complications and born mature or premature.
Material and methods. A prospective follow-up monitoring of 47 patients (inpatients of the State Novosibirsk Regional Clinical Hospital) with thrombotic complications, the analysis of their medical records were carried out. The homeostasis system parameters, carriage of polymorphic variants of genes predisposing to thrombotic complications were accomplished for the children during the follow-up period.
Results and discussion. Thrombotic and/or related ischemic events are more common in premature infants, herewith the severe cerebral ischemia and venous thrombosis localized in various vessels predominated over these complications. The state of the blood coagulation system in children with thrombotic/ischemic events is characterized by hypercoagulation shifts in the external and internal cascades of blood coagulation and accompanied by the increase in the D-dimers level. Among polymorphic variants of genes of hemostasis system the occurrence of polymorphic variant FV Leiden (rs6025) is higher in the study group compared to the European population (χ2 = 7.454; p = 0.025). The obtained data indicate the need for extended diagnostic studies of hemostasis system and genetic search for «thrombogenic» predisposition in children, especially premature, residing in intensive care units for the presence of thrombotic readiness in order to timely predict the development of possible thrombotic and ischemic complications.
About the Authors
T. V. Belousova
Novosibirsk State Medical University of Minzdrav of Russia
Russian Federation
doctor of medical sciences, professor
630091, Novosibirsk, Krasny av., 52
Russian Federation
doctor of medical sciences, professor
630091, Novosibirsk, Krasny av., 52
A. A. Leonova
Novosibirsk State Medical University of Minzdrav of Russia
Russian Federation
630091, Novosibirsk, Krasny av., 52
Russian Federation
630091, Novosibirsk, Krasny av., 52
V. A. Plyushkin
Novosibirsk State Medical University of Minzdrav of Russia
Russian Federation
candidate of medical sciences
630091, Novosibirsk, Krasny av., 52
Russian Federation
candidate of medical sciences
630091, Novosibirsk, Krasny av., 52
I. G. Grinberg
State Novosibirsk Regional Clinical Hospital
Russian Federation
630087, Novosibirsk, Nemirovich-Danchenko str., 130
Russian Federation
630087, Novosibirsk, Nemirovich-Danchenko str., 130
References
1. Vashukova E.S., Glotov A.S., Ivashchenko T.E. Modern approaches to diagnostics of thrombophilia hereditary forms. Rossiyskiy pediatricheskiy zhurnal = Russian Pediatric Journal. 2008; 5: 48–53. [In Russian].
2. Makatsariya A.D., Bitsadze V.O., Akin’shina S.V. Thrombosis and thromboembolism in obstetrics and gynecology clinic: molecular genetic mechanisms and prevention strategy for thromboembolic complications. Moscow: Meditsinskoye informatsionnoye agentstvo, 2007. 1064 p. [In Russian].
3. Momot A.P., Taranenko I.A., Tsyvkina L.P. Thrombotic state of readiness – the possibilities of modern diagnostics and prospects. Meditsinskiy alfavit = Medical Alphabet. 2013; 1 (3): 20–23. [In Russian]. doi: 10.18411/d-2016-062
4. Morozova N.Ya., Burov A.A., Dorofeeva E.I., Podurovskaya Yu.L. Experience of venous thrombosis management in newborns: two clinical observations. Neonatologiya: novosti, mneniya, obuchenie = Neonatology: News, Opinions, Training. 2017; (2): 91–98. [In Russian]. doi: 10.24411/2308-2402-2017-00032
5. Pikalov I.V. Mechanisms, diagnostics and ways of correction of the most important disorders of hemostasis in premature newborns. Abstract of thesis. … doct. med. sci. Barnaul, 1998. [In Russian].
6. Svirin P.V., Rumyantsev S.A., Larina L.E., Suvorova A.V., Zharkov A.P. Neonatal thrombosis: treatment regimen. Neonatologiya: novosti, mneniya, obuchenie = Neonatology: News, Opinions, Training. 2013; (1): 76–85. [in Russian].
7. Sibireva O.F., Hitrinskaya E.Yu., Ivanchuk I.I., Sazonov A.E., Kalyuzhin V.V. Distribution of frequencies of genotypes and alleles in genes II, V factors of blood coagulation and methylenetetrahydrofolate reductase among the population of Tomsk. Meditsinskaya genetika = Medical Genetics. 2008; 7 (5): 35−37. [In Russian].
8. Ali Z., Troncoso J.C., Fowler D.R. Recurrent cerebral venous thrombosis associated with heterozygote methylenetetrahydrofolate reductase C677T mutation and sickle cell trait without homocysteinemia: an autopsy case report and review of literature. Forensic Sci. Int. 2014; 242: e52–e55. doi: 10.1016/j.forsciint.2014.07.007.
9. Behrouzi R., Punter M. Diagnosis and management of cerebral venous thrombosis. Clin. Med. (Lond.). 2018; 18 (1): 75–79. doi: 10.7861/clinmedicine.18-1-75
10. Branchford B.R., Mourani P., Bajaj L., MancoJonson M., Wang M., Goldenberg N.A. Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation. Haematologica. 2012; 97 (4): 509–515. doi: 10.3324/haematol.2011.054775
11. Capecchi M., Abbattista M., Martinelli I. Cerebral venous sinus thrombosis. J. Thromb. Haemost. 2018; 16 (10): 1918–1931. doi: 10.1111/jth.14210
12. Carod-Artal F.J., Nunes S.V., Portugal D., Silva T.V., Vargas A.P. Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian stroke patients admitted to a rehabilitation hospital. Stroke. 2005; 36: 2012–2014.
13. Duran R., Biner B., Demir M., Celtik C., Karasalihoğlu S. Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clin. Appl. Thromb. Haemost. 2005; 11: 83–88.
14. Ferriero D.M., Fullerton H.J., Bernard T.J., Billinghurst L., Daniels S.R., DeBaun M.R., de Veber G., Ichord R.N., Jordan L.C., Massicotte P., Meldau J., Roach E.S., Smith E.R. Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2019; 50 (3): e51–e96. doi: 10.1161/STR.0000000000000183
15. Ghaznavi H., Soheili Z., Samiei S., Soltanpour M.S. Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population. Blood Coagul. Fibrinolysis. 2015; 26 (8): 869–873. doi: 10.1097/MBC.0000000000000292
16. Gupta T., Delhi Kumar C.G., Ramesh Kumar R., Adhisivam B. Pediatric thrombotic events: incidence, clinical risk factors and outcome. Indian J. Pediatr. 2019; 86 (3): 241–244. doi: 10.1007/s12098-018-2827-5
17. Lane D.A., Grant P.J. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood. 2000; 95 (5): 1517–1532.
18. Saracco P., Bagna R., Gentilomo C., Magarotto M., Viano A., Magnetti F., Giordano P., Luciani M., Molinari A.C., Suppiej A., Ramenghi L.A., Simioni P. Clinical data of neonatal systemic thrombosis. J. Pediatr. 2016; 171: 60–66. doi: 10.1016/j.jpeds.2015.12.035
19. Schneider S., Kapelushnik J., Kraus M., El Saied S., Levi I., Kaplan D.M. The association between otogenic lateral sinus thrombosis and thrombophilia – A long-term follow-up. Am. J. Otolaryngol. 2018; 39 (3): 299–302. doi: 10.1016/j.amjoto.2018.03.013
20. Will A. Neonatal haemostasis and the management of neonatal thrombosis. Br. J. Haematol. 2015; 169: 324–332. doi: 10.1111/bjh.13301
Review
Views:
241
Email this article 